Patent application number | Description | Published |
20090112469 | PERSONAL NAVIGATION SYSTEM - There is provided a personal navigation system, including a head-mounted orientation sensor, a coordinate position sensor, a head-mounted display, and a processor receiving an input from the head-mounted orientation sensor and an input from the coordinate position sensor and providing a visually sensible output for displaying on the head-mounted display. | 04-30-2009 |
20090153437 | DEVICE AND METHOD FOR ALIGNMENT OF BINOCULAR PERSONAL DISPLAY - There is provided a binocular device, including a rigid mechanical body supporting two image sources ( | 06-18-2009 |
20100189291 | OPTICAL PIN-POINT MICROPHONE - An optical pin-point microphone has a light source for directing a sensing beam to an object of interest so as to be reflected thereby as a reflected signal beam, a detector having multiple detector elements for receiving the reflected signal beam, and a summer for receiving signals from at least two of the detector elements and detecting, rectifying, amplifying and summing the received signals to generate a non-vanishing signal representative of an acoustic signal. | 07-29-2010 |
20120179369 | PERSONAL NAVIGATION SYSTEM - There is provided a personal navigation system, including a head-mounted orientation sensor, a coordinate position sensor, a head-mounted display, and a processor receiving an input from the head-mounted orientation sensor and an input from the coordinate position sensor and providing a visually sensible output for displaying on the head-mounted display. | 07-12-2012 |
Patent application number | Description | Published |
20100281567 | TRANSGENIC PLANTS HAVING ALTERED LEVELS OF AROMATIC AMINO ACIDS AND METABOLITES DERIVED THEREFROM - The present invention relates to means and methods for altering the level of at least one of the aromatic amino acids phenylalanine, tryptophan and tyrosine and secondary metabolites in plants. Particularly, the present invention discloses transgenic plants comprising polynucleotides encoding chorismate mutase and prephenate dehydratase enzymes, having elevated amounts of at least one of phenylalanine, tyrosine and modified amount of at least one secondary metabolite derived therefrom, and reduced amount of tryptophan and at least one secondary metabolite derived from tryptophan. | 11-04-2010 |
20110093986 | TOMATO SIMYB12 TRANSCRIPTION FACTOR AND GENETIC SELECTION THEREOF - The present invention discloses that down regulation of the SlMYB12 transcription factor results in the colorless peel y phenotype in tomato fruit. The present invention provides polynucleotides encoding the tomato SlMYB12 transcription factor and genetic markers derived therefrom, useful in the breeding of tomato plants having the colorless peel phenotype and in the production of transgenic plants having altered flavonoid content. | 04-21-2011 |
20130111631 | TRANSGENIC PLANTS HAVING ALTERED DAHP SYNTHASE ACTIVITY | 05-02-2013 |
20130198900 | "THIAMINE PYROPHOSPHATE (TPP) RIBOSWITCH MUTANTS PRODUCING VITAMIN B1 ENRICHED FOOD AND FEED CROPS" - The present invention provides bioengineered organisms producing elevated levels of thiamine and/or thiamine derivatives. Particularly, the present invention discloses that modifying TPP-responsive riboswitch results in accumulation of thiamine and/or its derivatives. | 08-01-2013 |
Patent application number | Description | Published |
20090025480 | System and Method for Optical Sensing of Surface Motions - There is provided an optical perturbation sensing system, including a probing beam incident on a medium, a sensing beam redirected from the medium and incident on a surface area of a photodetector, an array of photodetector elements, and a constructive combiner for constructively combining detected signals from the elements, to form a stronger detected signal. A method for detection of perturbations in a medium is also provided. The invention avoids the need for detection of the phase or the frequency variations of the scattered signal as used in the more complex hitherto-proposed approaches. | 01-29-2009 |
20090213385 | Multi-Phase Interferometer - An optical perturbation sensing system includes a probing beam incident on a medium with perturbations and a sensing beam redirected from the medium and incident on a surface area of a photodetector. A reference beam directed onto the photodetector surface forms, with the sensing beam, an interference pattern on the photodetector surface and a phase patterner with at least two phase regions across its section, generates different phases in different regions of the interference pattern. An array of photodetector elements detects each phase region of the interference pattern and a constructive combiner subtract pairs of the detected signals, squares the subtracted signal squares, and sums the squared signals to form a stronger detected signal with reduced intensity noise, reduced background noise, and reduced sensitivity to phase drifts. | 08-27-2009 |
Patent application number | Description | Published |
20090191173 | Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 - A method for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells comprises administering to an individual in need thereof an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide, a Copolymer 1-related peptide, and activated T cells which have been activated by Copolymer 1, a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide. The method is particularly useful for stem cell therapy in combination with the agent. | 07-30-2009 |
20100298227 | Treatment of autoimmune conditions with Copolymer 1 and related copolymers - The present invention is directed to polypeptides containing at least three amino acids randomly joined in a linear array; wherein at least one of the three amino acids is an aromatic amino acid, at least one of the three amino acids is a charged amino acid and at least one amino acid is an aliphatic amino acid. In a preferred embodiment the polypeptide contains three or four of the following amino acids: tyrosine, alanine, glutamic acid or lysine. According to the present invention, the present polypeptides bind to antigen presenting cells, purified human lymphocyte antigens (HLA) and/or Copolymer 1-specific T cells. Moreover, according to the present invention, these polypeptides can be formulated into pharmaceutical compositions for treating autoimmune disease. The present invention further contemplates methods of treating an autoimmune disease in a mammal by administering a pharmaceutically effective amount of any one of the present polypeptides to the mammal. | 11-25-2010 |
20120135016 | INDUCTION OF NEUROGENESIS AND STEM CELL THERAPY IN COMBINATION WITH COPOLYMER 1 - A method for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells comprises administering to an individual in need thereof an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide, a Copolymer 1-related peptide, and activated T cells which have been activated by Copolymer 1, a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide. The method is particularly useful for stem cell therapy in combination with the agent. | 05-31-2012 |
20150030560 | TREATMENT OF AUTOIMMUNE CONDITIONS WITH COPOLYMER 1 AND RELATED COPOLYMERS - The present invention is directed to polypeptides containing at least three amino acids randomly joined in a linear array; wherein at least one of the three amino acids is an aromatic amino acid, at least one of the three amino acids is a charged amino acid and at least one amino acid is an aliphatic amino acid. In a preferred embodiment the polypeptide contains three or four of the following amino acids: tyrosine, alanine, glutamic acid or lysine. According to the present invention, the present polypeptides bind to antigen presenting cells, purified human lymphocyte antigens (HLA) and/or Copolymer 1-specific T cells. Moreover, according to the present invention, these polypeptides can be formulated into pharmaceutical compositions for treating autoimmune disease. The present invention further contemplates methods of treating an autoimmune disease in a mammal by administering a pharmaceutically effective amount of any one of the present polypeptides to the mammal. | 01-29-2015 |